{{Rsnum
|rsid=5030772
|Gene=FASLG
|Chromosome=1
|position=172664210
|Orientation=plus
|GMAF=0.06566
|Gene_s=FASLG
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 74.6 | 19.0 | 6.3
| HCB | 97.6 | 2.4 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 97.6 | 2.4 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23392773
|Title=Apoptosis-related Fas and FasL gene polymorphisms' associations with knee osteoarthritis
}}

{{PMID Auto
|PMID=23749041
|Title=Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.
}}

{{on chip | FTDNA}}